From 4minute mark
"In the Australian biotech sector there is zero correlation between MC and stage of lead asset in the pipeline"
"There are companies out there who aren't even in the clinic who are valued more than we are - and from a valuation point of view that makes zero sense."
Ann: SYNBV MoU Webinar presentation, page-15
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
-0.001(3.85%) |
Mkt cap ! $14.89M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.5¢ | 2.5¢ | $11.96K | 478.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1658821 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 226086 | 2 |
View Market Depth
| Last trade - 13.59pm 25/06/2024 (20 minute delay) ? |
| 1AD (ASX) Chart |